SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 110 filers reported holding SUTRO BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is 1.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $736,143 | -25.9% | 212,145 | -0.7% | 0.00% | – |
| Q2 2023 | $993,328 | +90038.7% | 213,619 | -10.4% | 0.00% | – |
| Q1 2023 | $1,102 | -34.5% | 238,461 | +14.6% | 0.00% | -100.0% |
| Q4 2022 | $1,682 | -99.9% | 208,130 | -9.7% | 0.00% | 0.0% |
| Q3 2022 | $1,280,000 | +6.1% | 230,604 | -0.4% | 0.00% | – |
| Q2 2022 | $1,206,000 | -18.7% | 231,472 | +24.4% | 0.00% | – |
| Q1 2022 | $1,483,000 | -45.3% | 186,132 | +2.2% | 0.00% | -100.0% |
| Q4 2021 | $2,711,000 | -59.9% | 182,200 | -49.1% | 0.00% | -50.0% |
| Q3 2021 | $6,767,000 | -10.4% | 358,261 | -11.8% | 0.00% | 0.0% |
| Q2 2021 | $7,551,000 | -13.9% | 406,195 | +5.4% | 0.00% | -33.3% |
| Q1 2021 | $8,768,000 | +52.8% | 385,228 | +45.7% | 0.00% | +50.0% |
| Q4 2020 | $5,738,000 | +421.6% | 264,323 | +141.5% | 0.00% | – |
| Q3 2020 | $1,100,000 | +179.9% | 109,441 | +115.7% | 0.00% | – |
| Q2 2020 | $393,000 | -2.5% | 50,735 | +28.6% | 0.00% | – |
| Q1 2020 | $403,000 | +34.3% | 39,441 | +44.8% | 0.00% | – |
| Q4 2019 | $300,000 | +16.7% | 27,239 | -3.5% | 0.00% | – |
| Q3 2019 | $257,000 | +41.2% | 28,234 | +77.0% | 0.00% | – |
| Q2 2019 | $182,000 | – | 15,955 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,675,579 | $5,814,259 | 1.78% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5,883,693 | $20,416,415 | 1.10% |
| Kynam Capital Management, LP | 1,552,675 | $5,387,782 | 0.88% |
| Parkman Healthcare Partners LLC | 1,182,168 | $4,102,123 | 0.75% |
| Rubric Capital Management LP | 3,344,810 | $11,606,491 | 0.44% |
| BVF INC/IL | 3,347,946 | $11,617,373 | 0.31% |
| DAFNA Capital Management LLC | 283,079 | $982,284 | 0.31% |
| SECTORAL ASSET MANAGEMENT INC | 432,339 | $1,500,216 | 0.29% |
| Eversept Partners, LP | 769,638 | $2,670,644 | 0.23% |
| Frazier Life Sciences Management, L.P. | 780,000 | $2,706,600 | 0.18% |